Cancer Biomarkers Market to Reach $35.16 Billion by 2031
The cancer biomarkers market is projected to grow at a CAGR of 8.65%, reaching USD 35.16 billion by 2031. Growth is driven by increasing cancer prevalence and rising adoption of precision oncology and early detection methods, according to Mordor Intelligence.
Menafn·


